ClearPoint Neuro, Inc. (CLPT)
9.14
-0.11
(-1.19%)
USD |
NASDAQ |
Oct 23, 16:00
9.20
+0.06
(+0.66%)
After-Hours: 20:00
ClearPoint Neuro Net Income (Quarterly) : -11.34M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.34M |
| March 31, 2026 | -9.552M |
| December 31, 2025 | -7.786M |
| September 30, 2025 | -5.891M |
| June 30, 2025 | -5.837M |
| March 31, 2025 | -6.026M |
| December 31, 2024 | -5.386M |
| September 30, 2024 | -4.974M |
| June 30, 2024 | -4.408M |
| March 31, 2024 | -4.146M |
| December 31, 2023 | -4.619M |
| September 30, 2023 | -4.809M |
| June 30, 2023 | -7.052M |
| March 31, 2023 | -5.609M |
| December 31, 2022 | -4.385M |
| September 30, 2022 | -3.788M |
| June 30, 2022 | -4.303M |
| March 31, 2022 | -3.959M |
| December 31, 2021 | -4.149M |
| September 30, 2021 | -3.98M |
| June 30, 2021 | -3.743M |
| March 31, 2021 | -2.538M |
| December 31, 2020 | -1.582M |
| September 30, 2020 | -1.484M |
| June 30, 2020 | -1.661M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.055M |
| December 31, 2019 | -1.646M |
| September 30, 2019 | -1.123M |
| June 30, 2019 | -1.550M |
| March 31, 2019 | -1.221M |
| December 31, 2018 | -1.218M |
| September 30, 2018 | -1.428M |
| June 30, 2018 | -1.876M |
| March 31, 2018 | -1.641M |
| December 31, 2017 | -2.082M |
| September 30, 2017 | -1.426M |
| June 30, 2017 | -2.004M |
| March 31, 2017 | -1.656M |
| December 31, 2016 | -1.681M |
| September 30, 2016 | -2.563M |
| June 30, 2016 | -1.782M |
| March 31, 2016 | -2.044M |
| December 31, 2015 | -1.198M |
| September 30, 2015 | -0.2454M |
| June 30, 2015 | -3.060M |
| March 31, 2015 | -3.945M |
| December 31, 2014 | -1.915M |
| September 30, 2014 | -3.647M |
| June 30, 2014 | -1.593M |
| March 31, 2014 | 2.630M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| SINTX Technologies, Inc. | -2.706M |
| Abbott Laboratories | 920.00M |
| AngioDynamics, Inc. | -7.097M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 10.88M |
| Total Expenses (Quarterly) | 22.22M |
| EPS Diluted (Quarterly) | -0.3758 |
| Enterprise Value | 313.38M |
| Gross Profit Margin (Quarterly) | 59.79% |
| Profit Margin (Quarterly) | -104.2% |
| Earnings Yield | -12.88% |
| Normalized Earnings Yield | -12.88 |